Roles Nrf2 Plays in Myeloid Cells and Related Disorders

被引:79
|
作者
Kobayashi, Eri [1 ]
Suzuki, Takafumi [1 ]
Yamamoto, Masayuki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
TRANSCRIPTION FACTOR NRF2; PROTEIN S-GUANYLATION; OXIDATIVE STRESS; NITRIC-OXIDE; LUNG INJURY; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; KEAP1-NRF2; PATHWAY; GENE-EXPRESSION; ACTIVATES NRF2;
D O I
10.1155/2013/529219
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Keap1-Nrf2 system protects animals from oxidative and electrophilic stresses. Nrf2 is a transcription factor that induces the expression of genes essential for detoxifying reactive oxygen species (ROS) and cytotoxic electrophiles. Keap1 is a stress sensor protein that binds to and ubiquitinates Nrf2 under unstressed conditions, leading to the rapid proteasomal degradation of Nrf2. Upon exposure to stress, Keap1 is modified and inactivated, which allows Nrf2 to accumulate and activate the transcription of a battery of cytoprotective genes. Antioxidative and detoxification activities are important for many types of cells to avoid DNA damage and cell death. Accumulating lines of recent evidence suggest that Nrf2 is also required for the primary functions of myeloid cells, which include phagocytosis, inflammation regulation, and ROS generation for bactericidal activities. In fact, results from several mouse models have shown that Nrf2 expression in myeloid cells is required for the proper regulation of inflammation, antitumor immunity, and atherosclerosis. Moreover, several molecules generated upon inflammation activate Nrf2. Although ROS detoxification mediated by Nrf2 is assumed to be required for anti-inflammation, the entire picture of the Nrf2-mediated regulation of myeloid cell primary functions has yet to be elucidated. In this review, we describe the Nrf2 inducers characteristic of myeloid cells and the contributions of Nrf2 to diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
    Tsuchida, Kouhei
    Tsujita, Tadayuki
    Hayashi, Makiko
    Ojima, Asaka
    Keleku-Lukwete, Nadine
    Katsuoka, Fumiki
    Otsuki, Akihito
    Kikuchi, Haruhisa
    Oshima, Yoshiteru
    Suzuki, Mikiko
    Yamamoto, Masayuki
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 103 : 236 - 247
  • [42] An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases
    Jiang, Shuai
    Yang, Yang
    Li, Tian
    Ma, Zhiqiang
    Hu, Wei
    Deng, Chao
    Fan, Chongxi
    Lv, Jianjun
    Sun, Yang
    Yi, Wei
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (12) : 1413 - 1424
  • [43] Protective Roles of Nrf2 in Disease including Oral Disease
    Yanagawa, Toru
    Itoh, Ken
    Ishii, Tetsuro
    JOURNAL OF ORAL BIOSCIENCES, 2005, 47 (02): : 126 - 134
  • [44] Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice
    Keleku-Lukwete, Nadine
    Suzuki, Mikiko
    Panda, Harit
    Otsuki, Akihito
    Katsuoka, Fumiki
    Saito, Ritsumi
    Saigusa, Daisuke
    Uruno, Akira
    Yamamoto, Masayuki
    BLOOD ADVANCES, 2019, 3 (08) : 1285 - 1297
  • [45] Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2
    You, Aram
    Nam, Chang-won
    Wakabayashi, Nobunao
    Yamamoto, Masayuki
    Kensler, Thomas W.
    Kwak, Mi-Kyoung
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 507 (02) : 356 - 364
  • [46] Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment
    Moon, Eui Jung
    Giaccia, Amato
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 79 : 292 - 299
  • [47] Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma
    Soini, Y.
    Eskelinen, M.
    Juvonen, P.
    Karja, V.
    Haapasaari, K. M.
    Saarela, A.
    Karihtala, P.
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (01) : 35 - 39
  • [48] NRF2 in Viral Infection
    Herengt, Angela
    Thyrsted, Jacob
    Holm, Christian K.
    ANTIOXIDANTS, 2021, 10 (09)
  • [49] NRF2 and the Hallmarks of Cancer
    de la Vega, Montserrat Rojo
    Chapman, Eli
    Zhang, Donna D.
    CANCER CELL, 2018, 34 (01) : 21 - 43
  • [50] Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
    Gall Troselj, Koraljka
    Tomljanovic, Marko
    Jaganjac, Morana
    Matijevic Glavan, Tanja
    Cipak Gasparovic, Ana
    Milkovic, Lidija
    Borovic Sunjic, Suzana
    Buttari, Brigitta
    Profumo, Elisabetta
    Saha, Sarmistha
    Saso, Luciano
    Zarkovic, Neven
    MOLECULES, 2022, 27 (05):